SCHEMBL3393884

SCHEMBL3393884

COc1c(Br)c(Cn2cnc3c(OC)ncnc32)c(Br)c(OC)c1OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 6/20 0.48
▸ HSP90AB1 P08238 6/20 0.48
▸ FLT4 P35916 1/20 0.47
▸ KDR P35968 1/20 0.47
▸ HPGD P15428 2/20 0.46
▸ NPSR1 Q6W5P4 2/20 0.43
▸ DAPK1 P53355 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ TAAR1 Q96RJ0 1/20 0.41
▸ LMNA P02545 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ NSD3 Q9BZ95 1/20 0.36
▸ ADORA2A P29274 1/20 0.35
▸ ADORA1 P30542 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3396083 0.83 HSP90AA1 (0.71) HSP90AA1HSP90AB1FLT4KDRHPGD
SCHEMBL3395811 0.76 HSP90AA1 (0.57) HSP90AA1HSP90AB1FLT4KDRHPGD
SCHEMBL17364335 0.75 ADORA2A (0.60) FLT4KDRHPGDNPSR1DAPK1
SCHEMBL22326733 0.73 ADORA2A (0.62) FLT4KDRHPGDDAPK1TAAR1
SCHEMBL24021954 0.72 FLT4 (0.53) FLT4KDRHPGDDAPK1TAAR1
SCHEMBL8769186 0.70 FLT4 (0.72) FLT4KDRHPGDDAPK1TAAR1
SCHEMBL22533420 0.69 HPGD (0.56) FLT4KDRHPGDNPSR1DAPK1
SCHEMBL8465881 0.68 ADORA2A (0.56) FLT4KDRHPGDTAAR1TSHR
SCHEMBL4379586 0.67 ADORA1 (0.56) FLT4KDRHPGDTAAR1ALDH1A1
SCHEMBL14659198 0.67 FLT4 (0.51) FLT4KDRHPGDDAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2145888-A1 Deazapurine derivatives as HSP90-Inhibitors Conforma Therapeutics Corporation (US) 2010-01-20 — — EP disclosed
EP-1670802-A2 NOVEL HETEROCYCLIC COMPOUNDS AS HSP90-INHIBITORS Conforma Therapeutic Corporation (US) 2006-06-21 — — EP disclosed
WO-2005028434-A2 NOVEL HETEROCYCLIC COMPOUNDS AS HSP90-INHIBITORS CONFORMA THERAPEUTICS CORPORATION (US) 2005-03-31 — — WO disclosed
Send feedback